CHO Pharma, Inc. 6586.TWO Stock
CHO Pharma, Inc. Price Chart
CHO Pharma, Inc. 6586.TWO Financial and Trading Overview
| CHO Pharma, Inc. stock price | 56.9 TWD |
| Previous Close | 79.2 TWD |
| Open | 80 TWD |
| Bid | 79.5 TWD x 0 |
| Ask | 80 TWD x 0 |
| Day's Range | 79.2 - 80.3 TWD |
| 52 Week Range | 59.8 - 193 TWD |
| Volume | 348.44K TWD |
| Avg. Volume | 1.15M TWD |
| Market Cap | 14.72B TWD |
| Beta (5Y Monthly) | 0.244863 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.6 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6586.TWO Valuation Measures
| Enterprise Value | 13.54B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 245325.33 |
| Price/Book (mrq) | 10.303967 |
| Enterprise Value/Revenue | 225657.73 |
| Enterprise Value/EBITDA | -41.702 |
Trading Information
CHO Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 0.244863 |
| 52-Week Change | -58.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 193 TWD |
| 52 Week Low | 59.8 TWD |
| 50-Day Moving Average | 93.39 TWD |
| 200-Day Moving Average | 128.45 TWD |
6586.TWO Share Statistics
| Avg. Volume (3 month) | 1.15M TWD |
| Avg. Daily Volume (10-Days) | 674.47K TWD |
| Shares Outstanding | 183.99M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -584833.29% |
| Gross Margin | 98.33% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.54% |
| Return on Equity (ttm) | -21.33% |
Income Statement
| Revenue (ttm) | 60K TWD |
| Revenue Per Share (ttm) | 0 TWD |
| Quarterly Revenue Growth (yoy) | -98.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | -324668000 TWD |
| Net Income Avi to Common (ttm) | -338392992 TWD |
| Diluted EPS (ttm) | -1.75 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.04B TWD |
| Total Cash Per Share (mrq) | 5.68 TWD |
| Total Debt (mrq) | 11.7M TWD |
| Total Debt/Equity (mrq) | 0.82 TWD |
| Current Ratio (mrq) | 6.391 |
| Book Value Per Share (mrq) | 7.764 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -249504000 TWD |
| Levered Free Cash Flow (ttm) | -140336624 TWD |
Profile of CHO Pharma, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | Building C |
| ZIP | 11571 |
| Phone | 886 2 2655 8059 |
| Website | https://www.chopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04 for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V07 glycan-based vaccines and drugs. The company was founded in 2013 and is based in Taipei City, Taiwan.
Q&A For CHO Pharma, Inc. Stock
What is a current 6586.TWO stock price?
CHO Pharma, Inc. 6586.TWO stock price today per share is 56.9 TWD.
How to purchase CHO Pharma, Inc. stock?
You can buy 6586.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CHO Pharma, Inc.?
The stock symbol or ticker of CHO Pharma, Inc. is 6586.TWO.
Which industry does the CHO Pharma, Inc. company belong to?
The CHO Pharma, Inc. industry is Biotechnology.
How many shares does CHO Pharma, Inc. have in circulation?
The max supply of CHO Pharma, Inc. shares is 214.01M.
What is CHO Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
CHO Pharma, Inc. PE Ratio is now.
What was CHO Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
CHO Pharma, Inc. EPS is -1.6 TWD over the trailing 12 months.
Which sector does the CHO Pharma, Inc. company belong to?
The CHO Pharma, Inc. sector is Healthcare.